Drug Trial Radar · NCT03583372
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).
Last checked: Nov 20, 2026Latest source record: Mar 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
506
Actual
Start
Jun 14, 2018
Primary completion
Jun 13, 2019
Study completion Jul 25, 2019
Sponsor
- Lead sponsor
- Urovant Sciences GmbHIndustry
- Sponsor type
- Industry
- First posted
- Jul 11, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the safety, tolerability, and efficacy of vibegron administered once daily in participants with OAB for up to 52 weeks.
Conditions
- Overactive Bladder
Interventions
VibegronDrug
single daily dose 75 mg
placebosDrug
placebo to match vibegron (experimental drug) and tolterodine (active comparator)
Tolterodine Tartrate ERDrug
single daily dose of 4 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With the Indicated Type of Treatment-emergent Adverse EventTime frame: up to 56 weeks
Locations
107 sites in 1 country. Site status is shown where the registry gives one.
Coastal Clinical Research Inc.
Mobile, Alabama
Clinical Research Consortium
Tempe, Arizona
Noble Clinical Research
Tucson, Arizona
Hope Clinical Research
Canoga Park, California
Core Healthcare Group
Cerritos, California
American Clinical Trials
Hawaiian Gardens, California
Grossmont Center for Clinical Research
La Mesa, California
Prime-Care Clinical Research
Laguna Hills, California
Long Beach Clinical Trials LLC
Long Beach, California
Downtown L.A. Research Center Inc.
Los Angeles, California
Tri Valley Urology Medical Group
Murrieta, California
Northern California Research
Sacramento, California
Artemis Institute for Clinical Research
San Diego, California
WR MCCCR
San Diego, California
Artemis Institute for Clinical Research
San Marcos, California
Bayview Research Group LLC
Valley Village, California
Horizons Clinical Research Center
Denver, Colorado
Lynn Institute of Denver
Denver, Colorado
Clinical Research Consulting LLC
Milford, Connecticut
Coastal Connecticut Research LLC
New London, Connecticut
Chase Medical Research, LLC
Waterbury, Connecticut
PAB Clinical Research
Brandon, Florida
Top Medical Research Inc.
Cutler Bay, Florida
Revival Research
Doral, Florida
Riverside Clinical Research
Edgewater, Florida
Indago Research Health Center
Hialeah, Florida
Best Quality Research, Inc.
Hialeah, Florida
Health Awareness, Inc.
Jupiter, Florida
San Marcus Research Clinic Inc.
Miami, Florida
LCC Medical Research Institute Inc.
Miami, Florida
Nuren Medical Research Center
Miami, Florida
AppleMed Research Group LLC
Miami, Florida
Miami Clinical Research
Miami, Florida
Advanced Medical Research Institute
Miami, Florida
Suncoast Clinical Research Inc.
New Port Richey, Florida
Bayside Clinical Research
New Port Richey, Florida
Compass Research LLC
Orlando, Florida
South Broward Research LLC
Pembroke Pines, Florida
Clinical Research Center of Florida
Pompano Beach, Florida
Clinical Research of West Florida
Tampa, Florida
Showing 40 of 107 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.